Turmeric Helps Prevent And Support The Treatment Of Gastrointestinal Cancers

One of the major obstacles to developing Curcumin (Curcuminoid or tech) as a cancer remedy is its low biological activity. However, clinical studies confirm the biological activity of curcumin can be achieved on the gastrointestinal tract after oral administration.
Cancer of the oral cavity and lower gland
Although studies on curcumin on oral cancers are small, Curcumin has been confirmed to have great promise in preventing oral cavities.
In an oral carcinogen model of mice with 7.12 - dimethylbenz [a] anthracene, it was shown that Curcumin when used alone in high doses or in combination with piperine significantly reduced oral carcinoma by its anti- lipidperoxydase enzyme and antioxidant activity along with its effect on carcinogens

.
Research in patients with oral cavity leukoplakia as precancerous lesions shows that the use of curcumin in combination with vitamins E and C may have anti-cancer activity by increasing local antioxidant activity, thus preventing lipidperoxydase process and DNA damage.
Studies show that curcumin can be inhibited as a prophylactic agent of oral cavity by inhibiting carcinogen activation by facilitating the expression and enhancement of Cytocrome P450 or CYP1B1 functions.
Stomach cancer
Esophageal cancer has 2 types: adenocarcinoma and squamous cell carcinoma Even with the recent advances in new treatments, the survival of esophageal cancer patients is still low.




While there is little hope of innovating the treatment of esophageal cancer, a few research centers have conducted a curcumin trial.
Research shows that in Curcumin patients with adenocarcinoma carcinoma inhibits the activity of NF-kB and promotes cancer cells to enter the natural death cycle.
In another study, Curcumin promotes cancer cells to enter the natural death cycle in both adenocarcinoma and squamous cell carcinoma.
In squamous cell carcinoma Curcumin reduces the activity of Prostaglandin E2, the molecule involved in cancer development in esophageal squamous cell carcinoma.
Stomach cancer
In gastric cancer, Helicobacter pylori infection of gastric epithelial cells is one of the main mechanisms of stomach cancer.
One of the mechanisms proposed for the development of Helicobacter pylori stomach cancer is the abnormal expression of the cytidin dexaminase enzyme that activates AID and the activation of NF-kB.
Therefore, Curcumin inhibits NF-kB which can be considered as a strong chemical prophylactic agent against carcinogenic by Helicobacter pylori Curcumin's prophylaxis for gastric cancer prevention has been implemented in Phase I clinical research.




See more: Discount 25% for gastrointestinal cancer screening
Clinical study of Curcumin on patients with family adenoma polyps
2/3 of the colon polyps is gland polyps As a general rule, the larger the adenoma, the higher the chance of cancer. Large polyps therefore need to be biopsied or removed completely and sent for pathological anatomy.
Colorectal cancer is the second leading cause of death, accounting for 14% of cancer deaths. Colorectal cancer can be prevented if precancerous polyps are detected early.
Curcumin clinical study on inflammatory bowel disease
Research conducted on patients by Holt et al. Shows that curcumin inhibits ulcerative colitis and irritable bowel syndrome.
Research results on volunteer patients show that relapse is reduced, symptom relief is improved, symptom improvement. The study was conducted on 207 patients who volunteered to take 2 turmeric capsules / day for 8 weeks showing significant improvement in symptoms.




The effect of curcumin on advanced pancreatic cancer patients
Results of clinical studies in patients with advanced pancreatic cancer showed that the use of curcumin did not cause any undesirable effects, a satisfactory result for a patient with a 73% reduction in tumor size, patients Other for good response can be appreciated.
The effect of curcumin on patients with hepatic endothelial hemangioma in Vietnam
In Vietnam we have used Curcumin to treat very well for a patient with hepatic endothelial hemangioma in a 5-month-old child.
Patients with multiple hemangiomas, large size liver (8 tumors) accounted for over 60% of the liver volume. At first, we contacted many pediatric centers, but we had a suggestion for liver transplant surgery.
While seemingly hopeless, trying Curcumin treatment showed that symptoms such as digestive disorders, jaundice, anorexia and hepatomegaly were reduced, children developed well physically. After 1 year of ultrasound examination, all the tumors of the liver were lost leaving only a few small scars.
This is the case of an endothelial hemangioma of the liver in the first infant and only effective treatment with Curcumin published in the world literature..

. Dịch vụ: Thiết kế website, quảng cáo google, đăng ký website bộ công thương uy tín